This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Fact checked by Jennifer Klump GLP-1 drugs may increase the risk of a severe form of macular degeneration in older adults with diabetes, according to a recent study published in JAMA Ophthalmology. A ...

After 40 years of age, regular eye check-up is essential to prevent age-related eye diseases, says Dr S Sumathi, clinical ...

AAVantgarde is now initiating ‘CELESTE’, a first-in-human Phase 1/2 clinical trial in the United States, to evaluate the safety, tolerability, and initial efficacy of AAVB-039 in patients with ...

Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...

Omega-3 fatty acids are a type of essential fats linked to many health benefits, such as heart health, reduced inflammation, ...

Sean Clark, the VP and general manager of Alcon’s Global Surgical Franchise, added: “Dry AMD is an area of significant unmet ...

Carrot juice provides several nutrients that support eye health, immune function, and skin health. Learn more about the ...

Excessive screen exposure, underlying health issues, heredity or poor diet—all these factors can gradually affect vision and worsen eye health. While most people rely on eye drops, medications and ...

Charles Bonnet Syndrome (CBS) is a rare visual condition causing vivid hallucinations, often seen in those with eye disorders.

PST-611-CT1 is a first-in-human single ascending dose study that aims to establish, in six to a maximum of 12 dry AMD/GA patients, the safety profile of the drug and validate the maximal tolerated ...